Summary: CVS Corp. - S&P Global Ratings’ Credit Research

Summary: CVS Corp.

Summary: CVS Corp. - S&P Global Ratings’ Credit Research
Summary: CVS Corp.
Published Sep 10, 2002
Published Sep 10, 2002
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

The ratings on CVS Corp. reflect the company's leading position in the favorably regarded drug store industry and the belief that management is committed to maintaining a moderate financial policy. CVS, with more than 4,000 units, is the nation's top chain drug retailer based on store count. Prescriptions, which comprise about 68% of the company's revenue, continue to drive growth and are expected to do so well into the future based on an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company has historically generated consistent operating performance but has had difficulty since the third quarter of 2001 due to a shortage of pharmacists in four of its major markets,

  
Report Type:

Summary

Ticker
Issuer
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

Summary: CVS Corp. – 2002/10/04 – US$ 225.00

Summary: CVS Corp. – 2003/01/08 – US$ 225.00

Summary: CVS Corp. – 2003/03/24 – US$ 225.00

Summary: CVS Corp. – 2003/06/30 – US$ 225.00

Summary: CVS Corp. – 2003/09/22 – US$ 225.00

CVS Corp. – 2002/07/24 – US$ 500.00

Summary: CVS Corp. – 2002/07/24 – US$ 225.00

Research Update: CVS Corp. – 2002/07/03 – US$ 225.00

Summary: CVS Corp. – 2001/11/01 – US$ 225.00

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Summary: CVS Corp." Sep 10, 2002. Alacra Store. May 12, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Corp-264180>
  
APA:
S&P Global Ratings’ Credit Research. (). Summary: CVS Corp. Sep 10, 2002. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Corp-264180>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.